NCT06565195View on ClinicalTrials.gov

A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease

PHASE1RecruitingINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

August 27, 2024

Primary Completion Date

May 5, 2029

Study Completion Date

May 5, 2029

Conditions
Parkinson's Disease
Interventions
DRUG

LY3962681

IT injection

OTHER

Placebo (aCSF)

IT injection

Trial Locations (2)

78744-1625

RECRUITING

Austin Clinic PPD, Austin

192-0071

RECRUITING

P-One Clinic, Keikokai Medical Corporation, Hachiōji

Sponsors
All Listed Sponsors
lead

Prevail Therapeutics

INDUSTRY